Details of the Drug
General Information of Drug (ID: DMG1CCR)
| Drug Name |
Anti-CEA designer T cell therapy
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Anti-CEA designer T cells, Beth Israel; Engineered T cells, Harvard/Immunomedics; Anti-CEA designer T cell therapy, Harvard/Immunomedics; Gene therapy (CEA+ adenocarcinoma), Beth Israel; Gene therapy (carcinoembryonic antigen), Harvard/Immunomedics; Gene therapy (CEA+ adenocarcinoma), Harvard/Immunomedics; T cell gene therapy (CEA, colon tumor), Harvard/Immunomedics
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
